Top Markets
Coin of the day
Jiangsu Hengrui Medicine Co., Ltd. Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd.

600276
Classement en actions #509
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Prix de l'action
$7.88
Capitalisation boursière
$50.25B
Changement (1 jour)
-1.11%
Changement (1 an)
-7.06%
Pays
CN
Échange Jiangsu Hengrui Medicine Co., Ltd. (600276)

Catégorie

Historique du prix de l'action pour Jiangsu Hengrui Medicine Co., Ltd. (600276)
Prix de clôture le plus élevé : $7.90 le 2026-08-01

Prix de clôture le plus bas : $0.04 le 2005-07-01
Historique du prix de l'action de Jiangsu Hengrui Medicine Co., Ltd. de 2005 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -3.56%
2025 33.70%
2024 2.96%
2023 15.17%
2022 -30.24%
2021 -37.82%
2020 50.21%
2019 73.88%
2018 25.89%
2017 85.51%
2016 3.95%
2015 100.95%
2014 12.39%
2013 42.52%
2012 4.92%
2011 -16.03%
2010 40.18%
2009 61.62%
2008 -8.70%
2007 153.91%
2006 239.46%
2005 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$171.67 -
DE
$166.06 27.73%
DE
$36.29 22.66%
JP
$228.90 41.12%
CH
$21.45 14.41%
IN